Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Yin, Hao, Song, Chun-Qing, Dorkin, Joseph R, Zhu, Lihua J, Li, Yingxiang, Wu, Qiongqiong, Park, Angela, Yang, Junghoon +14 more·2016·Nature Biotechnology

Cited by (874)

Items 201–300 of 874

  1. Engineering Precision Medicine
    Wujin Sun, Junmin Lee, Shiming Zhang, Cole Benyshek, Mehmet R. Dokmeci, Ali Khademhosseini · 2018 · Advanced Science
  2. Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.
    Elias Quijano, Raman Bahal, Adele S. Ricciardi, W. Mark Saltzman, Peter M. Glazer · 2017 · PubMed Central
  3. Advances in CRISPR/Cas9
    Youmin Zhu · 2022 · BioMed Research International
  4. The Promise and Challenge of In Vivo Delivery for Genome Therapeutics
    Ross C. Wilson, Luke A. Gilbert · 2017 · ACS Chemical Biology
  5. Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism
    Dwi U. Kemaladewi, Eleonora Maino, Elzbieta Hyatt, Huayun Hou, Maylynn Ding, Kara M Place, Xinyi Zhu, Prabhpreet S. Bassi, Zahra Baghestani, Amit G. Deshwar et al. · 2017 · Nature Medicine
  6. CRISPR–Cas13 Precision Transcriptome Engineering in Cancer
    Javier Tadeo Granados-Riveron, Guillermo Aquino‐Jarquín · 2018 · Cancer Research
  7. Biomaterials as vectors for the delivery of CRISPR–Cas9
    Joon H. Eoh, Luo Gu · 2019 · Biomaterials Science
  8. Genome editing in cardiovascular diseases
    Alanna Strong, Kiran Musunuru · 2016 · Nature Reviews Cardiology
  9. Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA
    Satoshi Uchida, Kazunori Kataoka · 2019 · Journal of Biomedical Materials Research Part A
  10. CRISPR–Cas9 Gene Editing: Curing Genetic Diseases by Inherited Epigenetic Modifications
    Nikhil Deep Kolanu · 2024 · Global Medical Genetics
  11. RNA Therapeutics in Cardiovascular Precision Medicine
    Ageliki Laina, Aikaterini Gatsiou, Georgios A. Georgiopoulos, Kimon S. Stamatelopoulos, Konstantinos Stellos · 2018 · Frontiers in Physiology
  12. Interface Engineering in Multiphase Systems toward Synthetic Cells and Organelles: From Soft Matter Fundamentals to Biomedical Applications
    Zhou Liu, Wen You Zhou, Qi Cheng, Tiantian Kong · 2020 · Advanced Materials
  13. Hallmarks of cancer: The CRISPR generation
    Colette Moses, Benjamín García‐Bloj, Alan R. Harvey, Pilar Blancafort · 2018 · European Journal of Cancer
  14. Light-induced liposomes for cancer therapeutics
    Wenjie Chen, Ewa Magdalena Goldys, Wei Deng · 2020 · Progress in Lipid Research
  15. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
    Nerea Zabaleta, Miren Barberia, Cristina Martín-Higueras, Natalia Zapata‐Linares, Isabel Betancor, Saray Rodríguez-Diaz, Rebeca Martínez-Turrillas, Laura Torella, África Vales, Cristina Olagüe et al. · 2018 · Nature Communications
  16. Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases
    Ankit Kumar Dubey, Vijai Kumar Gupta, Małgorzata Kujawska, Gorka Orive, Nam‐Young Kim, Chen-Zhong Li, Yogendra Kumar Mishra, Ajeet Kumar Kaushik · 2022 · Journal of nanostructure in chemistry
  17. A new developing class of gene delivery: messenger RNA-based therapeutics
    Meng Zhao, Jonathan O’Keeffe Ahern, Jing Lyu, Luca Pierucci, Dezhong Zhou, Wenxin Wang · 2017 · Biomaterials Science
  18. Nanomaterial‐Based Organelles Protect Normal Cells against Chemotherapy‐Induced Cytotoxicity
    Ruibo Zhao, Xueyao Liu, Xinyan Yang, Biao Jin, Changyu Shao, Weijia Kang, Ruikang Tang · 2018 · Advanced Materials
  19. Multifunctional Branched Nanostraw-Electroporation Platform for Intracellular Regulation and Monitoring of Circulating Tumor Cells
    Gen He, Jianming Feng, Aihua Zhang, Lingfei Zhou, Rui Wen, Jiangming Wu, Chengduan Yang, Yang Jiang, Chunwei Li, Demeng Chen et al. · 2019 · Nano Letters
  20. Prediction of off-target specificity and cell-specific fitness of CRISPR-Cas System using attention boosted deep learning and network-based gene feature
    Qiao Liu, Di He, Lei Xie · 2019 · PLoS Computational Biology
  21. Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA
    Xianming Zhang, Hua Jin, Xiaojia Huang, Birendra Chaurasiya, Daoyin Dong, Thomas P. Shanley, You‐Yang Zhao · 2022 · Cell Reports
  22. Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins
    Yamin Li, Tao Yang, Yingjie Yu, Nicola Shi, Liu Yang, Zachary Glass, Justin Bolinger, Isaac James Finkel, Wenhan Li, Qiaobing Xu · 2018 · Biomaterials
  23. Exosome/Liposome-like Nanoparticles: New Carriers for CRISPR Genome Editing in Plants
    Alghuthaymi, Mousa A., Ahmad, Aftab, Khan, Zulqurnain, Khan, Sultan Habibullah, Ahmed, Farah K., Faiz, Sajid, Nepovimova, Eugenie, Kuča, Kamil, Abd-Elsalam, Kamel A. · 2021 · International Journal of Molecular Sciences
  24. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli‐Responsive Vehicles
    Weiqi Cai, Tianli Luo, Lanqun Mao, Ming Wang · 2020 · Angewandte Chemie International Edition
  25. RNA delivery biomaterials for the treatment of genetic and rare diseases
    Zhao, Weiyu, Hou, Xucheng, Vick, Olivia G., Dong, Yizhou · 2019 · Biomaterials
  26. Materials for Improving Immune Cell Transfection
    Arun R. K. Kumar, Yufeng Shou, Brian Chan, L. Krishaa, Andy Kah Ping Tay · 2021 · Advanced Materials
  27. Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders
    Kathleen A. Christie, David Courtney, Larry DeDionisio, Connie Chao-Shern, Shyamasree De Majumdar, Laura Mairs, M. Andrew Nesbit, Tara Moore · 2017 · Scientific Reports
  28. A Self-restricted CRISPR System to Reduce Off-target Effects
    Chen, Yanhao, Liu, Xiaojian, Zhang, Yongxian, Wang, Hui, Ying, Hao, Liu, Mingyao, Li, Dali, Lui, Kathy O, Ding, Qiurong · 2016 · Molecular Therapy
  29. Genome editing methods in animal models
    Hyunji Lee, Da Eun Yoon, Kyoungmi Kim · 2020 · Animal Cells and Systems
  30. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
    Bin Liu, Ali Saber, Hidde J. Haisma · 2019 · Drug Discovery Today
  31. Recent advances in liposome formulations for breast cancer therapeutics
    Biyao Yang, Bo-ping Song, Shaina Shankar, Anna Guller, Wei Deng · 2021 · Cellular and Molecular Life Sciences
  32. Precise genome-editing in human diseases: mechanisms, strategies and applications
    Yanjiang Zheng, Yifei Li, Kaiyu Zhou, Tiange Li, Nathan J. VanDusen, Yimin Hua · 2024 · Signal Transduction and Targeted Therapy
  33. Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation
    Chih‐Che Shen, Mu‐Nung Hsu, Chin-Wei Chang, Mei‐Wei Lin, Jih Ru Hwu, Yi Tu, Yu‐Chen Hu · 2018 · Nucleic Acids Research
  34. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery
    Savan K. Patel, Margaret M. Billingsley, Alvin J. Mukalel, Ajay S. Thatte, Alex G. Hamilton, Ningqiang Gong, Rakan D. El-Mayta, Hannah C. Safford, Maria I. Merolle, Michael J. Mitchell · 2023 · Theranostics
  35. Delivery of an Artificial Transcription Regulator dCas9-VPR by Extracellular Vesicles for Therapeutic Gene Activation
    Duško Lainšček, Lucija Kadunc, Mateja Manček Keber, Iva Hafner‐Bratkovič, Rok Romih, Roman Jerala · 2018 · ACS Synthetic Biology
  36. Application of CRISPR/Cas9 in Alzheimer’s Disease
    Likui Lu, Yu Xi, Yongle Cai, Miao Sun, Hao Yang · 2021 · Frontiers in Neuroscience
  37. Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans
    Jasper A. Soppe, Robert Jan Lebbink · 2017 · Trends in Microbiology
  38. In Vivo Genome Editing as a Therapeutic Approach
    Beatrice Xuan Ho, Sharon Jia Hui Loh, Woon‐Khiong Chan, Boon-Seng Soh · 2018 · International Journal of Molecular Sciences
  39. Gene therapy for liver diseases — progress and challenges
    Nerea Zabaleta, Carmen Unzu, Nicholas D. Weber, Gloria González‐Aseguinolaza · 2023 · Nature Reviews Gastroenterology & Hepatology
  40. CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
    Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya L. Saraswat, Saurabh Sharma, Jasmin D. Monpara, Anisha A. D’souza, Deepakkumar Mishra, Kamatham Pushpa Tryphena, Satoru Kawakita, Shahid Ullah Khan et al. · 2023 · Advanced Science
  41. In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency
    Chun‐Qing Song, Dan Wang, Tingting Jiang, Kevin W. O’Connor, Qiushi Tang, Lingling Cai, Xiangrui Li, Zhiping Weng, Hao Yin, Guangping Gao et al. · 2018 · Human Gene Therapy
  42. Cas9-nickase–mediated genome editing corrects hereditary tyrosinemia in rats
    Yanjiao Shao, Liren Wang, Nana Guo, Shengfei Wang, Lei Yang, Yajing Li, Mingsong Wang, Shuming Yin, Honghui Han, Li Zeng et al. · 2018 · Journal of Biological Chemistry
  43. Fluorinated Acid‐Labile Branched Hydroxyl‐Rich Nanosystems for Flexible and Robust Delivery of Plasmids
    Qi Yu, Haiqing Song, Haihua Xiao, Gang Cheng, Bingran Yu, Fu‐Jian Xu · 2018 · Small
  44. CRISPR/Cas9 – Mediated Precise Targeted Integration In Vivo Using a Double Cut Donor with Short Homology Arms
    Xuan Yao, Xing Wang, Junlai Liu, Xinde Hu, Linyu Shi, Xiaowen Shen, Wenqin Ying, Xin-Yao Sun, Xin Wang, Pengyu Huang et al. · 2017 · EBioMedicine
  45. Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing
    Arezoo Mohammadian Farsani, Negin Mokhtari, Saghi Nooraei, Howra Bahrulolum, Ali Akbari, Zoheir Mohammadian Farsani, Seyedmoein Khatami, Mozhdeh Sadat Ebadi, Gholamreza Ahmadian · 2024 · Heliyon
  46. Recent advances in polymeric materials for the delivery of RNA therapeutics
    David Ulkoski, Annette Bak, John T. Wilson, Venkata Ramanan Krishnamurthy · 2019 · Expert Opinion on Drug Delivery
  47. Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior
    Miles Aaron Miller, Ralph Weissleder · 2016 · Advanced Drug Delivery Reviews
  48. mRNA-based therapeutics–Advances and perspectives
    Olga V. Sergeeva, Victor Koteliansky, Timofei S. Zatsepin · 2016 · Biochemistry (Moscow)
  49. Lessons from Enzyme Kinetics Reveal Specificity Principles for RNA-Guided Nucleases in RNA Interference and CRISPR-Based Genome Editing
    Namita Bisaria, Inga Jarmoskaite, Daniel Herschlag · 2017 · Cell Systems
  50. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice
    Shen Shen, Minerva E. Sanchez, Keith Blomenkamp, Erik M. Corcoran, Eugenio Marco, Clifford Yudkoff, Haiyan Jiang, Jeffrey H. Teckman, David A. Bumcrot, Charles F. Albright · 2018 · Human Gene Therapy
  51. Strategies for In Vivo Genome Editing in Nondividing Cells
    Fatemeharefeh Nami, Mohsen Basiri, Leila Satarian, Cameron Curtiss, Hossein Baharvand, Catherine M. Verfaillie · 2018 · Trends in biotechnology
  52. Safe CRISPR: Challenges and Possible Solutions
    Michael Pineda, Ashley Lear, James P. Collins, Samira Kiani · 2018 · Trends in biotechnology
  53. Reversible Click Chemistry for Ultrafast and Quantitative Formation of Protein–Polymer Nanoassembly and Intracellular Protein Delivery
    Bin Liu, Margareta Ianosi-Irimie, S. Thayumanavan · 2019 · ACS Nano
  54. Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group
    Alessia Cavazza, Francisco J. Molina-Estévez, Álvaro Plaza Reyes, Víctor Ronco-Díaz, Asma Naseem, Špela Malenšek, Peter Pečan, Annalisa Santini, Paula Heredia, Araceli Aguilar-González et al. · 2025 · Molecular Therapy — Nucleic Acids
  55. In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
    Roselena Silvestri Schuh, Édina Poletto, Gabriela Pasqualim, Ângela Maria Vicente Tavares, Fabíola Shons Meyer, Esteban Alberto Gonzalez, Roberto Giugliani, Úrsula da Silveira Matte, Hélder Ferreira Teixeira, Guilherme Baldo · 2018 · Journal of Controlled Release
  56. Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
    Huan Deng, Wei Huang, Zhiping Zhang · 2019 · Nano Research
  57. Ionizable lipid-assisted efficient hepatic delivery of gene editing elements for oncotherapy
    Chunhui Li, Tongren Yang, Yuhua Weng, Mengjie Zhang, Deyao Zhao, Shuai Guo, Bo Hu, Wanxuan Shao, Xiaoxia Wang, Abid Hussain et al. · 2021 · Bioactive Materials
  58. CRISPR FISHer enables high-sensitivity imaging of nonrepetitive DNA in living cells through phase separation-mediated signal amplification
    Xin-Yuan Lyu, Yuan Deng, Xiaoyan Huang, Zhenzhen Li, Guo-Qing Fang, Yang Dong, Feng-Liu Wang, Wang Kang, En-Zhi Shen, Chun‐Qing Song · 2022 · Cell Research
  59. CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector
    Giridhar Murlidharan, Kensuke Sakamoto, Lavanya Rao, Travis Corriher, Dan Wang, Guangping Gao, Patrick M. Sullivan, Aravind Asokan · 2016 · Molecular Therapy — Nucleic Acids
  60. Nanoparticles-mediated CRISPR/Cas9 delivery: Recent advances in cancer treatment
    Shahin Aghamiri, Sam Talaei, Afshin Abdi Ghavidel, Farshid Zandsalimi, Saeid Masoumi, Nahid Heidari Hafshejani, Vahid Jajarmi · 2020 · Journal of Drug Delivery Science and Technology
  61. Harnessing lipid nanoparticles for efficient CRISPR delivery
    Jingyue Yan, Diana D. Kang, Yizhou Dong · 2021 · Biomaterials Science
  62. A history of genome editing in mammals
    Almudena Fernández, Santiago Josa, Lluı́s Montoliu · 2017 · Mammalian Genome
  63. In utero adenine base editing corrects multi-organ pathology in a lethal lysosomal storage disease
    Bose, Sourav K., White, Brandon M., Kashyap, Meghana V., Dave, Apeksha, De Bie, Felix R., Li, Haiying, Singh, Kshitiz, Menon, Pallavi, Wang, Tiankun, Teerdhala, Shiva et al. · 2021 · Nature Communications
  64. Evolving AAV-delivered therapeutics towards ultimate cures
    Xijing He, Brian Anugerah Urip, Zhenjie Zhang, Chun Christopher Ngan, Bo Feng · 2021 · Journal of Molecular Medicine
  65. CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo
    Hyung Ho Yoon, Sunghyeok Ye, Sunhwa Lim, Ara Jo, Hawon Lee, Felix Hong, Seung Eun Lee, Soo‐Jin Oh, Narae Kim, Kyoungmi Kim et al. · 2022 · The CRISPR Journal
  66. The future of liver transplantation
    Sandy Feng, Garrett Richard Roll, Foad J. Rouhani, Alberto Sanchez Fueyo · 2024 · Hepatology
  67. CRISPR-Cas9 system: A genome-editing tool with endless possibilities
    Swati Tyagi, Robin Kumar, Aparup Das, So Youn Won, Pratyoosh Shukla · 2020 · Journal of Biotechnology
  68. Genome editing in cardiovascular diseases
    Indra Mani · 2021 · Progress in molecular biology and translational science
  69. Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector
    Han Zhang, Nathan Bamidele, Pengpeng Liu, Ogooluwa Ojelabi, Xin D. Gao, Tomás Rodríguez, Haoyang Cheng, Karen L. Kelly, Jonathan K. Watts, Jun Xie et al. · 2022 · GEN Biotechnology
  70. Targeted Gene Editing of Glia Maturation Factor in Microglia: a Novel Alzheimer’s Disease Therapeutic Target
    Sudhanshu P. Raikwar, Ramasamy Thangavel, Iuliia Dubova, Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, Duraisamy Kempuraj, Smita A. Zaheer, Shankar S. Iyer, Asgar Zaheer · 2018 · Molecular Neurobiology
  71. Engineered Interactions with Mesoporous Silica Facilitate Intracellular Delivery of Proteins and Gene Editing
    Bin Liu, Wardah Ejaz, Shuai Gong, Myrat Kurbanov, Mine Canakci, Francesca Anson, S. Thayumanavan · 2020 · Nano Letters
  72. Gene editing and its applications in biomedicine
    Guanglei Li, Xiangyang Li, Songkuan Zhuang, Liren Wang, Yifan Zhu, Yangcan Chen, Wen Ce Sun, Zeguang Wu, Zhuo Long Zhou, Jia Chen et al. · 2022 · Science China Life Sciences
  73. Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
    Xiaoqiang Huang, Dongshan Yang, Jifeng Zhang, Jie Xu, Y. Eugene Chen · 2022 · Cells
  74. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy
    Ke Yi, Huimin Kong, Yeh‐Hsing Lao, Di Li, Rachel L. Mintz, Tianxu Fang, Guojun Chen, Yu Tao, Mingqiang Li, Jianxun Ding · 2023 · Advanced Materials
  75. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length
    Kaitlin Mrksich, Marshall Scott Padilla, Ryann A. Joseph, Emily Laura Han, Dongyoon Kim, Rohan Palanki, Junchao Xu, Michael J. Mitchell · 2024 · Journal of Biomedical Materials Research Part A
  76. Advances in RNA-based therapeutics: current breakthroughs, clinical translation, and future perspectives
    Sarbjeet Kaur Makkar · 2025 · Frontiers in Genetics
  77. Optimization of lipid-assisted nanoparticle for disturbing neutrophils-related inflammation
    Yang Liu, Zhiting Cao, Cong‐Fei Xu, Zi-Dong Lu, Ying‐Li Luo, Jun Wang · 2018 · Biomaterials
  78. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy
    Le Wang, Wenfu Zheng, Shaoqin Liu, Bing Jhang Li, Xingyu Jiang · 2018 · ChemBioChem
  79. Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection
    Zhifen Cui, Cong Zeng, Furong Huang, Fuwen Yuan, Jingyue Yan, Yue Zhao, Yufan Zhou, William Hankey, Victor X. Jin, Jiaoti Huang et al. · 2022 · Nature Chemical Biology
  80. Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
    Panayiota L. Papasavva, Marina Kleanthous, Carsten Werner Lederer · 2019 · Molecular Diagnosis & Therapy
  81. Non-viral strategies for delivering genome editing enzymes
    Jie Li, Joachim Justad Røise, Maomao He, Riddha Das, Niren Murthy · 2020 · Advanced Drug Delivery Reviews
  82. Spatial and Temporal Control of CRISPR-Cas9-Mediated Gene Editing Delivered via a Light-Triggered Liposome System
    Yagiz Alp Aksoy, Biyao Yang, Wenjie Chen, Tzong‐Tyng Hung, Rhiannon P. Kuchel, Nathan W. Zammit, Shane T. Grey, Ewa Magdalena Goldys, Wei Deng · 2020 · ACS Applied Materials & Interfaces
  83. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential
    Erik Oude Blenke, Martijn J.W. Evers, Enrico Mastrobattista, John van der OOST · 2016 · Journal of Controlled Release
  84. Customizing the genome as therapy for the β-hemoglobinopathies.
    Canver, Matthew C., Orkin, Stuart H. · 2016 · Blood
  85. Delivery technologies for in utero gene therapy
    Palanki, Rohan, Peranteau, William H., Mitchell, Michael J. · 2021 · Advanced Drug Delivery Reviews
  86. Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia
    Dominique L. Ouellet, Khadija Cherif, J Rousseau, Jacques P. Tremblay · 2016 · Gene Therapy
  87. Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
    Li, Hao, Sheng, Chunyu, Liu, Hongbo, Wang, Shan, Zhao, Jiangyun, Yang, Lang, Jia, Leili, Li, Peng, Wang, Ligui, Xie, Jing et al. · 2018 · Frontiers in Immunology
  88. CRISPR/Cascade 9-Mediated Genome Editing-Challenges and Opportunities
    Bhaskar Roy, Jing Crystal Zhao, Chao Yang, Wen Luo, Teng Xiong, Yong Li, Xiaodong Fang, Guanjun Gao, Chabungbam Orville Singh, Lise Madsen et al. · 2018 · Frontiers in Genetics
  89. CRISPR/Cas9 system: a reliable and facile genome editing tool in modern biology
    Darakhshan Javaid, Shahid Yousuf Ganie, Younis Ahmad Hajam, Mohd Salim Reshi · 2022 · Molecular Biology Reports
  90. Mammalian Synthetic Biology: Engineering Biological Systems
    Joshua B. Black, Pablo Pérez‐Piñera, Charles A. Gersbach · 2017 · Annual Review of Biomedical Engineering
  91. Recent developments in intracellular protein delivery
    Yumiao Zhang, Joachim Justad Røise, Kunwoo Lee, Jie Li, Niren Murthy · 2018 · Current Opinion in Biotechnology
  92. Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9‐Mediated Knockin of Retinoschisin 1 Gene—A Potential Nonviral Therapeutic Solution for X‐Linked Juvenile Retinoschisis
    Shih‐Jie Chou, Peng Yang, Qian Ban, Yi Ping Yang, Mong‐Lien Wang, Chian‐Shiu Chien, Shih Jen Chen, Na Sun, Yazhen Zhu, Hongtao Liu et al. · 2020 · Advanced Science
  93. Progress and challenges towards CRISPR/Cas clinical translation
    Daniel Rosenblum, Anna Gutkin, Niels Dammes, Dan Peer · 2020 · Advanced Drug Delivery Reviews
  94. Delivery Approaches for Therapeutic Genome Editing and Challenges
    Ilayda Ates, Tanner Rathbone, Callie Stuart, P. Hudson Bridges, Renee N. Cottle · 2020 · Genes
  95. Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases
    Alessia De Caneva, Fabiola Porro, Giulia Bortolussi, Riccardo Sola, Michela Lisjak, Adi Barzel, Mauro Giacca, Mark A. Kay, Kristian Vlahoviček, Lorena Zentilin et al. · 2019 · JCI Insight
  96. CRISPR-Cas9-Mediated In Vivo Gene Integration at the Albumin Locus Recovers Hemostasis in Neonatal and Adult Hemophilia B Mice
    Qingnan Wang, Xiaomei Zhong, Qian Li, Jing Su, Yi Liu, Li Mo, Hongxin Deng, Yang Yang · 2020 · Molecular Therapy — Methods & Clinical Development
  97. The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy
    Ning Guo, Jibin Liu, Wen Li, Yu‐Shui Ma, Da Fu · 2021 · Journal of Advanced Research
  98. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system
    Xinchi Jiang, Tianyuan Zhang, Jianqing Gao · 2022 · Advanced Drug Delivery Reviews
  99. Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers
    Jessica A. Kretzmann, Cameron W. Evans, Colette Moses, Anabel Sorolla, Amy L. Kretzmann, Edina Wang, Diwei Ho, Mark J. Hackett, Benjamin Frederik Dessauvagie, Nicole M. Smith et al. · 2019 · Chemical Science
  100. Nanobiomaterial vectors for improving gene editing and gene therapy
    Shao Wei Hu, Tao Ding, Honghai Tang, Huiping Guo, Wenguo Cui, Yilai Shu · 2023 · Materials Today